Aptamer-Functionalized Drug Nanocarrier Improves Hepatocellular Carcinoma toward Normal by Targeting Neoplastic Hepatocytes
Open Access
- 4 February 2020
- journal article
- research article
- Published by Elsevier BV in Molecular Therapy Nucleic Acids
- Vol. 20, 34-49
- https://doi.org/10.1016/j.omtn.2020.01.034
Abstract
No abstract availableKeywords
Funding Information
- (UGC), New Delhi, India (1-10/2012(NS/PE))
This publication has 69 references indexed in Scilit:
- Anti-leukemic activity of Wattakaka volubilis leaf extract against human myeloid leukemia cell linesJournal of Ethnopharmacology, 2012
- Aptamer-functionalized PEG–PLGA nanoparticles for enhanced anti-glioma drug deliveryBiomaterials, 2011
- Evaluation of biosafety and intracellular uptake of Cremophor EL free paclitaxel elastic liposomal formulationDrug Delivery, 2011
- Novel Aptamer-Nanoparticle Bioconjugates Enhances Delivery of Anticancer Drug to MUC1-Positive Cancer Cells In VitroPLOS ONE, 2011
- Microtubule-targeted agents: When mitochondria become essential to chemotherapyBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2011
- Recent advances in apoptosis, mitochondria and drug resistance in cancer cellsBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2011
- Apoptosis signal-regulating kinase 1 inhibits hepatocarcinogenesis by controlling the tumor-suppressing function of stress-activated mitogen-activated protein kinaseJournal of Hepatology, 2011
- Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?Nature Reviews Drug Discovery, 2009
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingAnalytical Biochemistry, 1976
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976